U.S. approves two Novartis blood pressure pills
ZURICH (Reuters) - U.S. regulators have approved two single-pill high blood pressure drugs, Diovan HCT and Exforge, from Switzerland's Novartis AG, the drugmaker said on Monday.
Both combination medicines were approved as initial therapies in patients likely to need multiple drugs to treat their high blood pressure, Novartis said in a statement.
(Reporting by Sam Cage)
© Thomson Reuters 2008 All rights reserved
Ads by Career Builder
Healthcare IT Research Director
Details: ...conduct ongoing healthcare IT-related research...level of value to healthcare delivery organizations...business issues to a healthcare or vendor client...
Director of Development-Healthcare
Details: ...of Development-Healthcare Director of Development...of Development-Healthcare position, and have...background that includes:Healthcare, Director of Development...
Vice President of Healthcare Sales
Details: ...President of Healthcare Sales is...develop the healthcare services market...President of Healthcare Sales prospects...
Medical & Healthcare Opportunities
Details: ...in life. Medical / Healthcare Some of the opportunities...in the Medical and Healthcare area include: Dental...







